About the Authors
- Mary F. Kearney, Jonathan Spindler, Sloane Yu, Elizabeth M. Anderson, Carry Poethke, Nicholas Kovacs, Frank Maldarelli
- HIV-1 Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America
- Wei Shao
- Advanced Biomedical Computing Center, SAIC, Frederick, Maryland, United States of America
- Angeline O'Shea, Catherine Rehm
- Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, NIH Bethesda, Maryland, United States of America
- John W. Mellors
- Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America
- John M. Coffin
- Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America
John Mellors is a consultant for Gilead Sciences and owns share options in RFS Pharmaceuticals. This does not alter our adherence to all PLoS Pathogens policies on sharing data and materials.
Conceived and designed the experiments: MFK JWM JMC FM. Performed the experiments: MFK JS SY. Analyzed the data: WS EMA NK. Contributed reagents/materials/analysis tools: MFK FM AOS CR CP. Wrote the paper: MFK JWM JMC FM.